In individuals with sarcopenia, the expression levels of TNF‐α typically rise, activating the NF‐κB inflammatory pathway, leading to an increase in the release of pro‐inflammatory cytokines, exacerbating muscle inflammation and atrophy. The gene discussed is TNF; the disease is sarcopenia.